Skip to main content
SpringerLink
Log in

Liver: Oncology/Trauma

  • Chapter
  • First Online:
Book cover Gastrointestinal Interventional Radiology

Part of the book series: Clinical Gastroenterology ((CG))

  • 539 Accesses

Abstract

Interventional radiology plays a large role in the management of patients with liver disease, particularly in those patients with liver cancer and in the setting of trauma. The treatment options and strategies for the management of hepatocellular carcinoma are complex and require a multidisciplinary approach. This chapter focuses on providing an overview of the imaging diagnosis and classification of hepatocellular carcinoma and examining the various treatment options that can be provided by minimally invasive techniques performed by interventional radiology. In addition, the interventional radiologists’ role in the management of patients with traumatic liver injury is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention. National vital statistics reports 1999–2013: chronic liver disease and cirrhosis. 2017. https://urldefense.proofpoint.com/v2/url?u=http-3A__www.cdc.gov_nchs_fastats_liver-2Ddisease.htm&d=DwMFaQ&c=vh6FgFnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8&r=43fkppBaj-NTFf-VE6tbGdRVXVBNSGwtGUrHy3XwlhQ&m=N-jlMHEPo8n2uhLtFVE2i3EKreidel980WqmFXjtfMo&s=v6ZcuSOXZ5zNv_zUVOoBTjrhKDOn0FU5z_Raye12DNw&e=” www.cdc.gov/nchs/fastats/liver-disease.htm. Accessed 5 Sept 2018.

  2. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2001;9:5224.

    Google Scholar 

  3. Bruix J, Sherman M. Managemetn of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.

    Article  Google Scholar 

  4. Crocetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol. 2017;72:626–35.

    Article  CAS  Google Scholar 

  5. Forner A, Reig ME, de Lope CR, et al. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(01):61–74.

    Article  CAS  Google Scholar 

  6. Ozakyol A. Global epidemiology of hepatocellular carcinoma. J Gastrointest Cancer. 2017;48(3):238–40.

    Article  Google Scholar 

  7. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis. 2005;25:133–42.

    Article  Google Scholar 

  8. Mitchell DG, Bruix J, Sherman M, et al. LI-RADS: summary, discussion, consensus of the LI-RADS Management Working Group and future directions. Hepatology. 2015;61(3):1056–65.

    Article  Google Scholar 

  9. McEvoy S, McCarthy C, Lavelle L, et al. Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American Association for the Study of Liver Disease. Radiographics. 2013;33(6):1653–68.

    Article  Google Scholar 

  10. Mitchell DG, Bruix J, Sherman M, Sirlin CB. Liver imaging reporting and data system: summary, discussion and consensus of the LI-RADS Management working group and future. Hepatology. 2015;61(3):1056–65.

    Article  Google Scholar 

  11. Freeman RB, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8(9):851–8.

    Article  Google Scholar 

  12. Levy I, Greig PD, Gallinger S, et al. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg. 2001;234:206–9.

    Article  CAS  Google Scholar 

  13. Corcetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol. 2017;72:636–5.

    Article  Google Scholar 

  14. Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):835–53.

    Article  Google Scholar 

  15. Kokudo N, Hasegawa K, Akahane M, et al. Evidence-based clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology. Hepatol Res. 2015;45(2):123–7.

    Article  Google Scholar 

  16. Bolondi L, Burroughs A, Dufour JF, et al. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for sub-classification to facilitate treatment decisions. Semin Liver Dis. 2012;32(4):348–59.

    CAS  PubMed  Google Scholar 

  17. Raoul J, Sangro B, Forner A, Mazzaferro V, Piscagelia F, Bolondi L, Lencioni R. Evolving strategies for the managmenet of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev. 2011;37(3):212–20.

    Article  Google Scholar 

  18. Llovet J, Bruix J. Systematic review of randomized trials for unresectable hepatoceullular carcinoma: chemoembolization improves survival. Hepatology. 2003;37(2):429–42.

    Article  CAS  Google Scholar 

  19. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–40.

    Article  CAS  Google Scholar 

  20. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR. 1993;160:1023–8.

    Article  CAS  Google Scholar 

  21. Lin SM, Lin CJ, Lin CC, et al. Randomized control trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection and percutaneous acetic acid injection to treat HCC of 3cm or less. Gut. 2005;54(8):1151–6.

    Article  CAS  Google Scholar 

  22. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology. 2001;34:707–13.

    Article  CAS  Google Scholar 

  23. Ahmed M, Brace C, Lee F, Goldberg S. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–69.

    Article  Google Scholar 

  24. Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984;143:125–42.

    Article  Google Scholar 

  25. Sanghvi NT, Hawes RH. High-intensity focused ultrasound. Gastrointestinal Endos Clin North Am. 1994;4(2):383–95.

    Article  CAS  Google Scholar 

  26. McGahan JP, Dodd GD. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol. 2001;176:3–16.

    Article  Google Scholar 

  27. Wood BK, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer. 2002;94:443–51.

    Article  Google Scholar 

  28. Simon C, Dupuy D, Mayo-Smith W. Microwave ablation: principles and applications. Radiographics. 2005;25(1):S69–83.

    Article  Google Scholar 

  29. Skinner M, Iizuka M, Kolios M, Sherar M. A theoretical comparison of energy sources—microwave, ultrasound and laser—for interstitial thermal therapy. Phys Med Biol. 1998;43:3535–47.

    Article  CAS  Google Scholar 

  30. Edd J, Horowitz L, Davalos R, et al. In vivo results of new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng. 2006;53:1409–15.

    Article  Google Scholar 

  31. Lo C, Ngan H, Tso W, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–71.

    Article  CAS  Google Scholar 

  32. Huang K, Zhou Q, Wang R, et al. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29:920–5.

    Article  CAS  Google Scholar 

  33. Llovet JM, Real MI, Montana X, et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359:1734–9.

    Article  Google Scholar 

  34. Kawai S, Okamura J, Ogawa M, et al. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma – a comparison of lipiodol transcatheter arterial embolization with and without adriamycin. Cancer Chemother Pharmacol. 1992;21:1–6.

    Article  Google Scholar 

  35. Chang JM, Tzeng WS, Pan HB, et al. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer. 1994;74:2449–53.

    Article  CAS  Google Scholar 

  36. Graziadei IW, Sandmueller H. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl. 2003;9:557–63.

    Article  Google Scholar 

  37. Llovet JM, Bruix J. A systematic review of randomized control trials for unresectable hepatocellular carcinoma chemoembolization improves survival. Hepatology. 2003;37:429–42.

    Article  CAS  Google Scholar 

  38. Dawson LA. Hepatic arterial yttrium-90 microspheres: another treatment option for hepatocellular carcinoma. J Vasc Interv Radiol. 2005;16(2):161–4.

    Article  Google Scholar 

  39. Popperl G, Helmberger T, Munzing W, et al. Selective internal radiation therapy with SIR-spheres in patients with nonresectable liver tumors. Cancer Biother Radiopharm. 2005;2:200–8.

    Article  Google Scholar 

  40. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2000;4:1023–33.

    Article  Google Scholar 

  41. Carretero C, Munoz-Navas M, Betes M, et al. Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol. 2007;6:1216–20.

    Article  Google Scholar 

  42. Liapi E, Geschwind J-FH. Radioembolization for hepatocellular carcinoma (chapter 65). In: Mauro MA, et al., editors. Image-guided interventions. 2nd ed. Philadelphia: Elsevier; 2014. p. 441–7.

    Google Scholar 

  43. Hilgard P, Hamami M, Fouly AE, et al. Radioembolization with ytrrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology. 2010;52(5):1741–9.

    Article  CAS  Google Scholar 

  44. Salem R, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres. A comprehensive report of long-term outcomes. Gastroenterology. 2009;138(1):52–64.

    Article  Google Scholar 

  45. Lewandowski RJ, Kulik LM, Riaz A, et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant. 2009;9(8):1920–8.

    Article  CAS  Google Scholar 

  46. Huber-Wagner S, Lefering R, Quick L, et al. Effect of whole-body CT during trauma resuscitation on survival: a retrospective multicenter study. Lancet. 2009;373:1455–61.

    Article  Google Scholar 

  47. Yu W-Y, Li Q-J, Gong J-P. Treatment strategy for hepatic trauma. Chin J Traumatol. 2016;19:168–71.

    Article  Google Scholar 

  48. Steichen FM. Hepatic trauma in adults. Surg Clin North Am. 1975;55:387–407.

    Article  CAS  Google Scholar 

  49. Rose SC, Moore EE. Emergency trauma angiography: accuracy, safety and pitfalls. Am J Roentgenol. 1987;148:1243–6.

    Article  CAS  Google Scholar 

  50. Salazar G, Walker TG. Evaluation and management of acute vascular trauma. Tech Vasc Interv Radiol. 2009;12:102–16.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Interventional Radiology, Massachusetts General Hospital, Boston, MA, USA

    Elizabeth Anne C. Hevert & Suvranu Ganguli

Authors
  1. Elizabeth Anne C. Hevert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suvranu Ganguli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suvranu Ganguli .

Editor information

Editors and Affiliations

  1. Department of Interventional Radiology, University of Connecticut Health Center, Farmington, CT, USA

    Charan K. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hevert, E.A.C., Ganguli, S. (2018). Liver: Oncology/Trauma. In: Singh, C. (eds) Gastrointestinal Interventional Radiology . Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-91316-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91316-2_8

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-91315-5

  • Online ISBN: 978-3-319-91316-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation